Emily Shen

Emily Shen has extensive experience in global product labeling and regulatory affairs, currently serving as Director at Pfizer since July 2016. Prior to this role, Emily held positions as Associate Director, Global Labeling at Bristol-Myers Squibb and Associate Director in Regulatory Affairs/Labeling at AstraZeneca Pharmaceuticals, where responsibilities included the development of global product labeling for chemical entities and biologics. Emily also served as Associate Director of Global Labeling at Wyeth Pharmaceuticals, focusing on structured product labeling and PLR submissions. Earlier in Emily's career, discovery research was conducted in women's health and neuroscience at DuPont Merck Pharmaceutical Company. Emily holds a Post-doctoral Fellowship in Molecular Pharmacology from Stanford University School of Medicine, a PhD in Pharmacology from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, an M.S. in Pharmacology and Toxicology from the University of Minnesota, and an A.B. in Biology from Bryn Mawr College.